{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:18:14Z","timestamp":1790803094674,"version":"4.1.0"},"reference-count":84,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0119271","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T14:03:05Z","timestamp":1425650585000},"page":"e0119271","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pertussis Post-Exposure Prophylaxis among Household Contacts: A Cost-Utility Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Nisha","family":"Thampi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Gurol-Urganci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha S.","family":"Crowcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"key":"ref1","first-page":"1","article-title":"The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study","volume":"14","author":"JD Cherry","year":"1984","journal-title":"Curr Probl Pediatr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(82)92214-0","article-title":"The recurrence of whooping cough: possible implications for assessment of vaccine efficacy","volume":"1","author":"PE Fine","year":"1982","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"AM Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7326\/0003-4819-128-1-199801010-00010","article-title":"Pertussis in adults","volume":"128","author":"JD Cherry","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/clinids\/14.2.464","article-title":"A search for Bordetella pertussis infection in university students","volume":"14","author":"CM Mink","year":"1992","journal-title":"Clin Infect Dis"},{"key":"ref6","unstructured":"Public Health Ontario. Monthly Infectious Diseases Surveillance Report\u2014June. 2012. Available: http:\/\/www.publichealthontario.ca\/en\/DataAndAnalytics\/Documents\/2012_June_PHO_Monthly_Report.pdf<\/ext-link>."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/cid\/cis888","article-title":"Epidemiologic and Laboratory Features of a Large Outbreak of Pertussis-Like Illnesses Associated With Cocirculating Bordetella holmesii and Bordetella pertussis\u2014Ohio, 2010\u20132011","volume":"56","author":"L Rodgers","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"c4627","DOI":"10.1136\/bmj.c4627","article-title":"Whooping cough outbreak hits several US states","volume":"341","author":"B Roehr","year":"2010","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpeds.2012.05.041","article-title":"California pertussis epidemic, 2010","volume":"161","author":"K Winter","year":"2012","journal-title":"J Pediatr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jpeds.2012.07.014","article-title":"Responding to pertussis","volume":"161","author":"TA Clark","year":"2012","journal-title":"J Pediatr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"NP Klein","year":"2012","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1542\/peds.2011-2594","article-title":"Why do pertussis vaccines fail?","volume":"129","author":"JD Cherry","year":"2012","journal-title":"Pediatrics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1542\/peds.104.4.e42","article-title":"A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection","volume":"104","author":"SA Halperin","year":"1999","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/pubmed\/24.3.200","article-title":"UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis","volume":"24","author":"H Dodhia","year":"2002","journal-title":"J Public Health Med"},{"key":"ref15","first-page":"1","article-title":"National Consensus Conference on Pertussis","volume":"2953","year":"2003","journal-title":"Canada Communicable Disease Report"},{"key":"ref16","first-page":"1","article-title":"Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines","volume":"54","author":"T Tiwari","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF01968151","article-title":"Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis","volume":"8","author":"JE Hoppe","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1542\/peds.114.1.e96","article-title":"Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis","volume":"114","author":"JM Langley","year":"2004","journal-title":"Pediatrics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00006454-200112000-00011","article-title":"Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial","volume":"20","author":"MH Lebel","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"ref20","unstructured":"Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies. 3rd ed. Ottawa, ON; 2006."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party","volume":"313","author":"MF Drummond","year":"1996","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"SD Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref23","unstructured":"Bureau of Labor Statistics. CPI Inflation Calculator. 2012. Available: http:\/\/www.bls.gov\/data\/inflation_calculator.htm<\/ext-link>."},{"key":"ref24","unstructured":"Bank of Canada. Exchange Rates. 2012. Available: http:\/\/www.bankofcanada.ca\/rates\/exchange<\/ext-link>."},{"key":"ref25","unstructured":"Bank of Canada. Inflation Calculator. 2012. Available: http:\/\/www.bankofcanada.ca\/rates\/related\/inflation-calculator\/<\/ext-link>."},{"key":"ref26","unstructured":"Bank of Canada. Year Average of Exchange Rates. 2012. Available: http:\/\/www.bankofcanada.ca\/stats\/assets\/pdf\/nraa-2012.pdf<\/ext-link>."},{"key":"ref27","unstructured":"Statistics Canada. Deaths and mortality rates, by age group and sex, Canada, provinces and territories, Table 102\u20130504. 2011. Available: http:\/\/www5.statcan.gc.ca\/cansim\/<\/ext-link>. Accessed 2014 March 28."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00006454-199511000-00009","article-title":"Field effectiveness of erythromycin prophylaxis to prevent pertussis within families","volume":"14","author":"G De Serres","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/clinids\/14.3.708","article-title":"Epidemiological features of pertussis in the United States, 1980\u20131989","volume":"14","author":"KM Farizo","year":"1992","journal-title":"Clin Infect Dis"},{"key":"ref30","first-page":"73","article-title":"Pertussis\u2014United States, 1997\u20132000","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.inf.0000247055.81541.04","article-title":"The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada","volume":"26","author":"JA Bettinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.inf.0000160918.72953.51","article-title":"Pertussis immunization of adolescents in the United States: an economic evaluation","volume":"24","author":"JJ Caro","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJM197910253011703","article-title":"Pertussis vaccine\u2014an analysis of benefits, risks and costs","volume":"301","author":"JP Koplan","year":"1979","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0140-6736(99)10073-4","article-title":"Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study","volume":"354","author":"MA Honein","year":"1999","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1067\/mpd.2001.117577","article-title":"Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis","volume":"139","author":"BE Mahon","year":"2001","journal-title":"J Pediatr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.inf.0000253063.87338.60","article-title":"Infantile hypertrophic pyloric stenosis in infants treated with azithromycin","volume":"26","author":"W Morrison","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"ref37","unstructured":"Ontario Ministry of Health and Long-Term Care. Ontario Drug Benefit Formulary\/Comparative Drug Index No. 41. 2008. Available: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/formulary\/edition_41.pdf<\/ext-link>."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7525-3-17","article-title":"Health-state valuations for pertussis: methods for valuing short-term health states","volume":"3","author":"GM Lee","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"ref39","unstructured":"Ontario Ministry of Health and Long-Term Care. Ontario Case Costing Initiative. 2011. Available: http:\/\/www.occp.com\/mainPage.htm<\/ext-link>."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amepre.2006.10.016","article-title":"Cost effectiveness of pertussis vaccination in adults","volume":"32","author":"GM Lee","year":"2007","journal-title":"Am J Prev Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1542\/peds.112.5.1069","article-title":"Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life","volume":"112","author":"AE Tozzi","year":"2003","journal-title":"Pediatrics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-5-57","article-title":"Hospitalization for pertussis: profiles and case costs by age","volume":"5","author":"JA O'Brien","year":"2005","journal-title":"BMC Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Carrington EV, Hall NJ, Pacilli M, Drake DP, Curry JI, Kiely EM, et al. Cost-effectiveness of laparoscopic versus open pyloromyotomy. J Surg Res. 2012.","DOI":"10.1016\/j.jss.2012.01.031"},{"key":"ref44","unstructured":"Government of Ontario. Schedule of benefits for physician services under the Health Insurance Act. 2012. Available: http:\/\/www.health.gov.on.ca\/english\/providers\/program\/ohip\/sob\/physserv\/a_consul.pdf<\/ext-link>. Accessed 2014 April 7."},{"key":"ref45","unstructured":"Ontario Ministry of Health and Long-Term Care. Ontario Drug Benefit Formulary\/Comparative Drug Index. 2013. Available: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/odbf_eformulary.aspx<\/ext-link>. Accessed 2015 February 1."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1001\/jama.290.22.2968","article-title":"Trends in pertussis among infants in the United States, 1980\u20131999","volume":"290","author":"M Tanaka","year":"2003","journal-title":"JAMA"},{"key":"ref47","first-page":"1","article-title":"CDC growth charts: United States","author":"RJ Kuczmarski","year":"2000","journal-title":"Adv Data"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1016\/j.vaccine.2010.07.010","article-title":"Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience","volume":"28","author":"B Sander","year":"2010","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e1000256","DOI":"10.1371\/journal.pmed.1000256","article-title":"Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis","volume":"7","author":"B Sander","year":"2010","journal-title":"PLoS Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e1463","DOI":"10.1542\/peds.2012-0175","article-title":"Patterns and costs of health care use of children with medical complexity","volume":"130","author":"E Cohen","year":"2012","journal-title":"Pediatrics"},{"key":"ref51","unstructured":"Statistics Canada. Canadian Vital Statistics, Birth and Death Databases and population estimates. 2012. Available: www5.statcan.gc.ca\/cansim<\/ext-link>. Accessed August 21, 2013"},{"key":"ref52","article-title":"Remaining life expectancy at age 25 and probability of survival to age 75, by socioeconomic status and Aboriginal ancestry","volume":"22","author":"M Tjepkema","year":"2011","journal-title":"Health Reports"},{"key":"ref53","unstructured":"WHO. WHO guide to cost-effectiveness analysis; 2003. Available: http:\/\/www.who.int\/choice\/publications\/p_2003_generalised_cea.pdf<\/ext-link>. Accessed 2013 March 20."},{"key":"ref54","article-title":"Decision Modelling for Health Economic Evaluationed","author":"A Briggs","year":"2006"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/01.inf.0000160929.35004.86","article-title":"Economic burden of pertussis and the impact of immunization","volume":"24","author":"JJ Caro","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1086\/652281","article-title":"Pertussis disease burden in the household: how to protect young infants","volume":"50","author":"SC de Greeff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.vaccine.2009.10.079","article-title":"Economic impact of the introduction of an acellular pertussis vaccine in Canada: a 6-year analysis","volume":"28","author":"M Iskedjian","year":"2010","journal-title":"Vaccine"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00019053-200119050-00009","article-title":"Economic evaluation of a new acellular vaccine for pertussis in Canada","volume":"19","author":"M Iskedjian","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.vaccine.2008.04.068","article-title":"Cost-effectiveness of adult pertussis vaccination in Germany","volume":"26","author":"GM Lee","year":"2008","journal-title":"Vaccine"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.clinthera.2010.07.017","article-title":"Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands","volume":"32","author":"TA Westra","year":"2010","journal-title":"Clin Ther"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(81)92638-6","article-title":"Prophylactic erythromycin for whooping-cough contacts","volume":"1","author":"PR Grob","year":"1981","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev. 2007: CD004404.","DOI":"10.1002\/14651858.CD004404.pub3"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0140-6736(06)68848-X","article-title":"Recent developments in pertussis","volume":"367","author":"NS Crowcroft","year":"2006","journal-title":"Lancet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/cid\/cir973","article-title":"A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel","volume":"54","author":"WP Goins","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00006454-199510000-00010","article-title":"Clinical course of pertussis in immunized children","volume":"14","author":"R Bortolussi","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/514792","article-title":"Epidemiological features of pertussis in hospitalized patients in Canada, 1991\u20131997: report of the Immunization Monitoring Program\u2014Active (IMPACT)","volume":"28","author":"SA Halperin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/315648","article-title":"Morbidity of pertussis in adolescents and adults","volume":"182","author":"G De Serres","year":"2000","journal-title":"J Infect Dis"},{"key":"ref68","first-page":"177","article-title":"Prevention of secondary transmission of pertussis in households with early use of erythromycin","volume":"146","author":"MA Sprauer","year":"1992","journal-title":"Am J Dis Child"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/infdis\/157.3.434","article-title":"Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled","volume":"157","author":"RW Steketee","year":"1988","journal-title":"J Infect Dis"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"e6284","DOI":"10.1371\/journal.pone.0006284","article-title":"Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects","volume":"4","author":"L Coudeville","year":"2009","journal-title":"PLoS One"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/01.inf.0000166156.14422.9b","article-title":"Clinical and economic effects of pertussis outbreaks","volume":"24","author":"JP Davis","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1542\/peds.2004-2509","article-title":"Pertussis in adolescents and adults: should we vaccinate?","volume":"115","author":"GM Lee","year":"2005","journal-title":"Pediatrics"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1086\/425006","article-title":"Societal costs and morbidity of pertussis in adolescents and adults","volume":"39","author":"GM Lee","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archfami.9.10.989","article-title":"Costs of illness due to Bordetella pertussis in families","volume":"9","author":"LH Lee","year":"2000","journal-title":"Arch Fam Med"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpedi.1997.02170380039006","article-title":"Economic impact of pertussis","volume":"151","author":"ME Pichichero","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-6296(96)00507-3","article-title":"Accounting for future costs in medical cost-effectiveness analysis","volume":"16","author":"D Meltzer","year":"1997","journal-title":"J Health Econ"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-6296(96)00506-1","article-title":"Economic foundations of cost-effectiveness analysis","volume":"16","author":"AM Garber","year":"1997","journal-title":"J Health Econ"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhealeco.2007.09.011","article-title":"Future costs in cost effectiveness analysis","volume":"27","author":"RH Lee","year":"2008","journal-title":"J Health Econ"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1503\/cmaj.051637","article-title":"Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children","volume":"175","author":"D Vickers","year":"2006","journal-title":"CMAJ"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1542\/peds.2004-2127","article-title":"Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health","volume":"115","author":"I Griebsch","year":"2005","journal-title":"Pediatrics"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/11591570-000000000-00000","article-title":"Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?","volume":"29","author":"WJ Ungar","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"ref82","first-page":"653","article-title":"Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience","volume":"11","author":"NJ Binkin","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bmj.1.6002.117","article-title":"Severity of notified whooping cough","volume":"1","author":"CL Miller","year":"1976","journal-title":"Br Med J"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0149-2918(96)80188-3","article-title":"A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children","volume":"18","author":"PI Oh","year":"1996","journal-title":"Clin Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0119271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T21:47:55Z","timestamp":1540331275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0119271"}},"subtitle":[],"editor":[{"given":"T. Mark","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0119271","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,6]]}}}